Fetal Alcohol Damage Prevention Study
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00696085 |
Recruitment Status :
Completed
First Posted : June 12, 2008
Last Update Posted : June 12, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Fetal Alcohol Syndrome Substance Abuse | Behavioral: Brief motivational intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 612 participants |
Allocation: | Non-Randomized |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Prevention |
Official Title: | Prevention of Fetal Alcohol Damage Using Maternal Blood Markers |
Study Start Date : | March 2004 |
Actual Primary Completion Date : | February 2008 |
Actual Study Completion Date : | February 2008 |
Arm | Intervention/treatment |
---|---|
I
Pregnant women are recruited and screened for alcohol use using a validated alcoholism screening questionnaire. Those who screen positive are then entered into the next phase of the study.
|
Behavioral: Brief motivational intervention
The women who have positive alcohol screening questionnaires and a random sample of women who screen negative are entered into the next phase of the study. They have blood drawn for the markers of alcohol use, are told of the results and are given brief intervention about alcohol use.
Other Names:
|
- Decrease in drinking [ Time Frame: during the pregnancy ]
- improved infant size [ Time Frame: after pregnancy finished ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Pregnant women seen at one of the obstetric clinics in the study and willing to give a blood sample
Exclusion Criteria:
- over 36 week gestation

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00696085
United States, Massachusetts | |
Massachusetts General Hospital | |
Boston, Massachusetts, United States, 02114 |
Principal Investigator: | Lewis B Holmes, M.D. | Massachusetts General Hospital |
Responsible Party: | Lewis B. Holmes, M.D., Chief, Genetics Unit, MassGeneral Hospital for Children |
ClinicalTrials.gov Identifier: | NCT00696085 |
Other Study ID Numbers: |
1999-P-008236/21 |
First Posted: | June 12, 2008 Key Record Dates |
Last Update Posted: | June 12, 2008 |
Last Verified: | June 2008 |
fetal alcohol exposure blood markers of alcohol use brief intervention |
Fetal Alcohol Spectrum Disorders Substance-Related Disorders Chemically-Induced Disorders Mental Disorders |
Fetal Diseases Pregnancy Complications Alcohol-Induced Disorders Alcohol-Related Disorders |